228 related articles for article (PubMed ID: 19892672)
21. Alpha-1 antitrypsin Null mutations and severity of emphysema.
Fregonese L; Stolk J; Frants RR; Veldhuisen B
Respir Med; 2008 Jun; 102(6):876-84. PubMed ID: 18353624
[TBL] [Abstract][Full Text] [Related]
22. SPARTA clinical trial design: exploring the efficacy and safety of two dose regimens of alpha1-proteinase inhibitor augmentation therapy in alpha1-antitrypsin deficiency.
Sorrells S; Camprubi S; Griffin R; Chen J; Ayguasanosa J
Respir Med; 2015 Apr; 109(4):490-9. PubMed ID: 25727857
[TBL] [Abstract][Full Text] [Related]
23. [PI*S and PI*Z alpha 1-antitrypsin deficiency: estimated prevalence and number of deficient subjects in Spain].
Blanco I; Fernández-Bustillo E; de Serres FJ; Alkassam D; Rodríguez Menéndez C
Med Clin (Barc); 2004 Dec; 123(20):761-5. PubMed ID: 15607066
[TBL] [Abstract][Full Text] [Related]
24. Liver function in alpha-1-antitrypsin deficient individuals at 37 to 40 years of age.
Mostafavi B; Diaz S; Tanash HA; Piitulainen E
Medicine (Baltimore); 2017 Mar; 96(12):e6180. PubMed ID: 28328804
[TBL] [Abstract][Full Text] [Related]
25. The liver in 30-year-old individuals with alpha(1)-antitrypsin deficiency.
Bernspång E; Carlson J; Piitulainen E
Scand J Gastroenterol; 2009; 44(11):1349-55. PubMed ID: 19891586
[TBL] [Abstract][Full Text] [Related]
26. Exhaled nitric oxide in patients with PiZZ phenotype-related alpha1-anti-trypsin deficiency.
Malerba M; Clini E; Cremona G; Radaeli A; Bianchi L; Corda L; Pini L; Ricciardolo F; Grassi V; Ambrosino N
Respir Med; 2001 Jun; 95(6):520-5. PubMed ID: 11421511
[TBL] [Abstract][Full Text] [Related]
27. Lung density associates with survival in alpha 1 antitrypsin deficient patients.
Green CE; Parr DG; Edgar RG; Stockley RA; Turner AM
Respir Med; 2016 Mar; 112():81-7. PubMed ID: 26874894
[TBL] [Abstract][Full Text] [Related]
28. The prevalence of bronchiectasis in patients with alpha-1 antitrypsin deficiency: initial report of EARCO.
Stockley RA; Pye A; De Soyza J; Turner AM; Miravitlles M;
Orphanet J Rare Dis; 2023 Aug; 18(1):243. PubMed ID: 37573351
[TBL] [Abstract][Full Text] [Related]
29. Intermediate alpha 1-antitrypsin deficiency PiSZ: a risk factor for pulmonary emphysema?
Seersholm N; Kok-Jensen A
Respir Med; 1998 Feb; 92(2):241-5. PubMed ID: 9616519
[TBL] [Abstract][Full Text] [Related]
30. Lung function in 30-year-old alpha-1-antitrypsin-deficient individuals.
Bernspång E; Wollmer P; Sveger T; Piitulainen E
Respir Med; 2009 Jun; 103(6):861-5. PubMed ID: 19181511
[TBL] [Abstract][Full Text] [Related]
31. Urinary excretion of desmosine (elastin cross-links) in subjects with PiZZ alpha-1-antitrypsin deficiency, a phenotype associated with hereditary predisposition to pulmonary emphysema.
Pelham F; Wewers M; Crystal R; Buist AS; Janoff A
Am Rev Respir Dis; 1985 Oct; 132(4):821-3. PubMed ID: 3876794
[TBL] [Abstract][Full Text] [Related]
32. Correlation between annual change in health status and computer tomography derived lung density in subjects with alpha1-antitrypsin deficiency.
Stolk J; Ng WH; Bakker ME; Reiber JH; Rabe KF; Putter H; Stoel BC
Thorax; 2003 Dec; 58(12):1027-30. PubMed ID: 14645966
[TBL] [Abstract][Full Text] [Related]
33. Rationale and Design of the Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis Study. Alpha-1 Protocol.
Strange C; Senior RM; Sciurba F; O'Neal S; Morris A; Wisniewski SR; Bowler R; Hochheiser HS; Becich MJ; Zhang Y; Leader JK; Methé BA; Kaminski N; Sandhaus RA;
Ann Am Thorac Soc; 2015 Oct; 12(10):1551-60. PubMed ID: 26153726
[TBL] [Abstract][Full Text] [Related]
34. Prevalence and impact of bronchiectasis in alpha1-antitrypsin deficiency.
Parr DG; Guest PG; Reynolds JH; Dowson LJ; Stockley RA
Am J Respir Crit Care Med; 2007 Dec; 176(12):1215-21. PubMed ID: 17872489
[TBL] [Abstract][Full Text] [Related]
35. The Malaysian experience in the typing of genetic variants of alpha-1-antitrypsin.
Desa NM; Ismail Z; Beran Z; Musa SH
Southeast Asian J Trop Med Public Health; 1995; 26 Suppl 1():311-4. PubMed ID: 8629132
[TBL] [Abstract][Full Text] [Related]
36. Small airway evaluation in three subjects with alpha-1 antitrypsin deficiency without diagnosed lung disease.
Ferrari da Cruz T; Rufino R; Lopes A; Henrique Costa C
BMJ Case Rep; 2021 Mar; 14(3):. PubMed ID: 33785603
[TBL] [Abstract][Full Text] [Related]
37. Lung Function and Health Status in Individuals with Severe Alpha-1-Antitrypsin Deficiency at the Age of 42.
Schramm GR; Mostafavi B; Piitulainen E; Wollmer P; Tanash HA
Int J Chron Obstruct Pulmon Dis; 2021; 16():3477-3485. PubMed ID: 34992356
[TBL] [Abstract][Full Text] [Related]
38. European screening for alpha
Greulich T; Averyanov A; Borsa L; Rozborilová E; Vaicius D; Major T; Chopyak V; Tudorache V; Konstantinova T; Camprubí S
Clin Respir J; 2017 Jan; 11(1):90-97. PubMed ID: 25919395
[TBL] [Abstract][Full Text] [Related]
39. Distribution of alpha(1)-antitrypsin alleles in patients with bronchiectasis.
Cuvelier A; Muir JF; Hellot MF; Benhamou D; Martin JP; Bénichou J; Sesboüé R
Chest; 2000 Feb; 117(2):415-9. PubMed ID: 10669684
[TBL] [Abstract][Full Text] [Related]
40. SZ alpha-1 antitrypsin deficiency and pulmonary disease: more like MZ, not like ZZ.
Franciosi AN; Carroll TP; McElvaney NG
Thorax; 2021 Mar; 76(3):298-301. PubMed ID: 32917839
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
